Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Houston TX, Austin TX, New Orleans LA, Orlando FL,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT07154706

Phase3, Recruiting

ETHAN - ET for Male BC

for
Male Breast Cancer, Hormone Receptor-positive Breast Cancer,
Location: Houston TX, Nashville TN, Jacksonville FL, Rochester MN,
Sponsor: Jose Pablo Leone

Sex: Male

Age: 18+

Code: NCT05501704

Phase2, Recruiting

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

for
Brain Metastases, Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05048212

Phase2, Recruiting

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

for
Mantle Cell Lymphoma, Non Hodgkin Lymphoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05529069

Phase2, Recruiting

Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial

for
Advanced Malignant Solid Neoplasm,
Location: Houston TX, Galveston TX, New Orleans LA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05327010

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

for
Relapsed and/or Refractory Multiple Myeloma (RRMM)
Location: Houston TX, Dallas TX, Atlanta GA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07222761

Phase3, Recruiting

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

for
Advanced Cancer, Clear Cell Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05663710

Phase1, Phase2, Recruiting

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype,
Location: Houston TX, San Antonio TX, Dallas TX, Chicago IL,
Sponsor: Debiopharm International SA

Sex: All

Age: 18+

Code: NCT05765812

Phase1, Phase2, Recruiting

tAN for Substance Use Disorder

for
Alcohol Use Disorder, Alcohol Abuse, Substance Use Disorders,
Location: Houston TX
Sponsor: Spark Biomedical, Inc.

Sex: All

Age: 18 - 64

Code: NCT07281261

Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Houston TX
Sponsor: Eikon Therapeutics

Sex: All

Age: 18+

Code: NCT07262619

Phase1, Phase2, Recruiting

A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Houston TX, San Antonio TX, La Jolla CA
Sponsor: OBI Pharma, Inc

Sex: All

Age: 18+

Code: NCT07124117

Phase1, Phase2, Recruiting

Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts

for
Breast Cancer
Location: Houston TX, Birmingham AL, Boca Raton FL, Detroit MI,
Sponsor: American College of Radiology

Sex: Female

Age: 45 - 70+

Code: NCT05625659

Recruiting

Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial

for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04693468

Phase1, Recruiting

Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors

for
Cancer-related Cognitive Dysfunction, Primary Brain Neoplasm
Location: Houston TX, Atlanta GA
Sponsor: Emory University

Sex: All

Age: 15 - 39

Code: NCT06799481

Recruiting

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

for
Rectal Adenocarcinoma, Stage I Rectal Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT02107105

Recruiting

Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial

for
Lung Carcinoma, Stage I Lung Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04789681

Phase2, Recruiting

A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

for
Solid Malignancies
Location: Houston TX, Dothan AL, Palo Alto CA
Sponsor: Immunome, Inc.

Sex: All

Age: 18+

Code: NCT07505771

Early_phase1, Recruiting

NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer

for
Locally-Advanced Non-Small Cell Lung Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07224152

Phase1, Phase2, Recruiting

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

for
Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus
Location: Humble TX, Lake Charles LA, Frisco TX, Tampa FL,
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07355218

Phase3, Recruiting

A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1

for
HIV
Location: Houston TX, Birmingham AL, Nashville TN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 55

Code: NCT07390955

Phase1, Recruiting